SYNT-002

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameSYNT-002

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionImmunomodulatorsFc receptors inhibitors

TargetsFc receptors

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSyntimmune Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSyntimmune Inc

Active IndicationsN/A

Inactive IndicationsMetabolic Diseases

ATC CodeN/A